Series B funding round for TILT Biotherapeutics raising $25M in May 2025
Series B funding round for TILT Biotherapeutics raising $25M in May 2025
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
TesiLEAD | Venture Capital | — |
| Venture Capital | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$91.9M
Top Valuation
-
TILT Biotherapeutics raised $25M in a Series B round.
The round was announced on 05/01/25.
The round was led by Lifeline Ventures, European Innovation Council, Stephen Industries, Tesi.